|
|
||||||||
Vascular and Interventional Radiology |
1 From the Departments of Radiology (T.L., G.B.C.V., M.W.d.H., K.Y.J.A.M.H., J.M.A.v.E.), Clinical Epidemiology and Medical Technology Assessment (A.G.H.K.), Epidemiology (P.J.N.), and Vascular Surgery (P.E.J.H.M.K., J.H.M.T.), Maastricht University Hospital, Peter Debijelaan 25, NL-6229 HX Maastricht, the Netherlands; and Department of Epidemiology, Maastricht University Medical School, Maastricht, the Netherlands (P.J.N.). From the 2002 RSNA Annual Meeting. Received January 17, 2004; revision requested March 31; revision received May 25; accepted July 1. Supported in part by the Dutch Heart Foundation, grant 98150. Address correspondence to T.L. (e-mail: leiner@rad.unimaas.nl).
| ABSTRACT |
|---|
|
|
|---|
MATERIALS AND METHODS: The institutional review board approved the study, and all patients provided signed informed consent. Two hundred ninety-five patients referred for diagnostic and preinterventional work-up of PAD with duplex US also underwent gadolinium-enhanced MR angiography. Data sets were reviewed for presence or absence of 50% or greater luminal reduction, which indicated hemodynamically significant stenosis, and to determine interobserver agreement. At duplex US, a peak systolic velocity ratio of 2.5 or greater indicated significant stenosis. Primary outcome measures were differences between duplex US and contrast-enhanced MR angiography in sensitivity and specificity for detection of significant stenosis, as assessed with the McNemar test, and interobserver agreement between the two contrast-enhanced MR angiogram readings, expressed as quadratic weighted
values. Intraarterial digital subtraction angiography (DSA) was the reference standard.
RESULTS: Two hundred forty-nine patients had at least one hemodynamically significant stenotic lesion at contrast-enhanced MR angiography, duplex US, or both examinations. One hundred fifty-two patients underwent intraarterial DSA. The quadratic weighted
for agreement regarding the presence of 50% or greater stenosis at contrast-enhanced MR angiography was 0.89 (95% confidence interval [CI]: 0.87, 0.91). Sensitivity of duplex US was 76% (95% CI: 69%, 82%); specificity, 93% (95% CI: 91%, 95%); and accuracy, 89%. Sensitivity and specificity of contrast-enhanced MR angiography were 84% (95% CI: 78%, 89%) and 97% (95% CI: 95%, 98%), respectively; accuracy was 94%. Sensitivity (P = .002) and specificity (P = .03) of contrast-enhanced MR angiography were significantly higher.
CONCLUSION: Results of this prospective comparison between contrast-enhanced MR angiography and duplex US provide evidence that contrast-enhanced MR angiography is more sensitive and specific for diagnosis and preinterventional work-up of PAD.
© RSNA, 2005
| INTRODUCTION |
|---|
|
|
|---|
Duplex ultrasonography (US) is widely used to determine the location, length, and severity of aortoiliac and femoropopliteal stenoses and obstructions. Duplex US was developed in the 1980s as an alternative to invasive intraarterial angiography, which is associated with local and systemic complications, and to acquire direct physiologic information about affected arteries. With duplex US, the severity of a stenosis can be determined by using peak systolic velocity (PSV) measurements in arteries with reduced luminal diameter, the PSV ratio at the site of the stenosis and the adjacent normal artery, the end-diastolic velocity, and other less firmly established criteria (6). The sensitivity and specificity of duplex US for the detection and grading of PAD are generally moderate to high, ranging from 70%90% (6). Contrast materialenhanced magnetic resonance (MR) angiography has been developed as an alternative imaging modality for the diagnostic work-up of patients suspected of having PAD (79). Thus far, mainly studies in which contrast-enhanced MR angiography was compared with intraarterial digital subtraction angiography (DSA) in patients who were already referred for intraarterial DSA have been reported. These studies are summarized in two relatively recently published meta-analyses (10,11). However, there are limited data on the accuracy of duplex US compared with that of contrast-enhanced MR angiography for the diagnosis of PAD in the same patient group.
Our aims in this study were to prospectively compare the diagnostic accuracies of duplex US and contrast-enhanced MR angiography and to assess interobserver agreement regarding contrast-enhanced MR angiography findings in patients suspected of having PAD.
| MATERIALS AND METHODS |
|---|
|
|
|---|
If the results of duplex US, MR angiography, or both examinations indicated the presence of a treatable stenosis (ie,
50% luminal reduction) in the aortoiliac or superficial femoral arteries, intraarterial DSA was recommended and considered the reference standard. Arteries below the knee were not evaluated in the current study because duplex US of these arteries is not routinely performed at our institution. For medical ethical reasons, patients with negative duplex US and MR angiography results did not undergo intraarterial DSA and were assumed to have no significant lesions in the aortoiliac or superficial femoral arteries.
On the basis of the results of analysis of data in the interventional radiology registry at our hospital, we expected to identify treatable lesions in the aortoiliac and superficial femoral arteries in 55% of the patients and assumed that in 20% of them, duplex US and MR angiography would differ in terms of demonstrating the presence of such lesions. The study was powered for the detection of a minimum difference in sensitivity between duplex US and MR angiography of 10%. We believed that a difference of approximately this magnitude would be clinically relevant. At a significance level of .05 (two sided) and a power of 80%, the target subject enrollment was set at 300 patients. The study was approved by the institutional review board, and all patients signed informed consent forms before being enrolled.
From September 1997 to June 2001, 1430 patients were referred for duplex US of the aortoiliac and/or superficial femoral arteries. Patients who were referred for follow-up of an intervention (n = 327) and those who were previously included in the study for complaints in the contralateral lower extremity (n = 51) were excluded from participation. Of the remaining 1052 patients, 390 patients who were chosen from a random sample of names taken from the vascular laboratory agenda every week were contacted. We were unable to include consecutive patients because our MR imaging unit could accommodate a maximum of five patients per week. Ninety-five of the patients contacted did not participate. Reasons for nonparticipation were claustrophobia (n = 9), presence of a pacemaker (n = 6) or other metal implant (n = 2), lack of availability when the MR imaging unit was available (n = 8), and nonwillingness (n = 70).
A total of 295 of the contacted patients were enrolled in the study and underwent both duplex US and MR angiography. Figure 1 shows the patient flow diagram. There were 95 women and 200 men, and the overall mean age was 63 years ± 10 (standard deviation) (range, 3987 years). The mean age of the women was 62 years ± 11 (range, 4380 years), and that of the men was 63 years ± 10 (range, 3987 years). The difference in age distribution between the men and women was not significant (P = .67, independent samples t test). Disease severities, mean resting and postexercise ABIs for symptomatic extremities, and risk factors are listed in Table 1. None of the 295 patients who underwent MR angiography and duplex US reported having any associated serious adverse events (eg, shortness of breath, nausea, vomiting, or other symptoms of contrast material allergy) or was medically treated or hospitalized as a result of undergoing either imaging procedure.
|
|
In every arterial segment that was accessible and that could be evaluated, the PSV ratio was measured and classified by using a five-category stenosis scale. In the aortoiliac and common femoral arteries, the end-diastolic velocity was also measured. Stenosis scale categories were as follows: A PSV ratio of less than 1.5 indicated 0%19% stenosis; a PSV ratio of greater than or equal to 1.5 but less than 2.5, 20%49% stenosis; a PSV ratio of greater than or equal to 2.5, 50%74% stenosis; a PSV ratio of greater than or equal to 2.5 plus an end-diastolic velocity of greater than 60 cm/sec, 75%99% stenosis; and no Doppler signal, occlusion (14,15). For the superficial femoral arteries, no differentiation was made between 0%19% and 20%49% stenosis or between 50%74% and 75%99% stenosis. The total examination time for aortoiliac duplex US was 4560 minutes; when the superficial femoral artery was also included, the total examination time was 6075 minutes.
Contrast-enhanced MR Angiography
All MR angiography examinations were performed by using a commercially available whole-body 1.5-T MR imaging system (Gyroscan ACS-NT and Intera; Philips Medical Systems, Best, the Netherlands) with standard hardware and software (releases 6.1, 7.1, and 8.1; Philips Medical Systems). Gradient strengths varied between 21 and 23 mT/m, and slew rates varied between 105 and 115 mT/m/msec. For depiction of aortoiliac and peripheral arteries, a stepping table approach was used (16). With this technique, high-spatial-resolution three-dimensional images of the peripheral arterial system, from the abdominal aorta to the ankles, were obtained during three acquisitions (for aortoiliac arteries and upper and lower leg arteries) in rapid succession. Patients were placed in the MR magnet bore feet first and in the supine position. Before image acquisition, venous access was established in an antecubital or hand vein by using an 18- or 19-gauge intravenous cannula (Venflon; Ohmeda, Helsingborg, Sweden).
To prescribe the imaging volumes for the MR angiogram acquisitions, nonenhanced time-of-flight images were acquired in all three stations (aortoiliac, upper leg, and lower leg arteries). We used a gradient-recalled-echo turbo field-echo pulse sequence with a flip angle sweep and a 180° inversion prepulse for optimal background tissue suppression. Parameters for the time-of-flight sequence were 15/6.9 (repetition time msec/echo time msec), a 50° flip angle, a 512 x 282-mm field of view, a 256 x 100 matrix, 20 transverse sections with a 2.5-mm thickness and a 20-mm intersection gap, and an inferior concatenated saturation band. For signal transmission and reception during the three time-of-flight acquisitions, a standard quadrature body coil was used. The total imaging time for each field of view with this sequence was 30 seconds. No cardiac synchronization was used. From these time-of-flight acquisitions, maximum intensity projections were generated in three orthogonal directions to prescribe the imaging volumes for the subsequent MR angiography examinations.
For all MR angiogram acquisitions, a gradient-recalled-echo fast field-echo pulse sequence was used; the parameters used are listed in Table 2. To enhance intravascular signal intensity, every patient was injected with a standard dose of 35 mL of 0.5 mmol/mL gadopentetate dimeglumine (Magnevist; Schering, Berlin, Germany). By using an MR imagingcompatible power injector (Medrad, Indianola, Pa), the contrast medium was administered as a single continuous bolus at rates varying between 0.4 and 1.8 mL/sec. Higher and dual-phase injection rates were used later in the study when the speed of image acquisition increased owing to improvements in gradient performance and newer software releases.
|
Before the acquisition of all contrast-enhanced MR angiograms, identical nonenhanced angiograms were obtained; these images were subtracted from the postinjection images to increase vessel-to-background contrast. Patients were asked to perform breath holding for the duration of the aortoiliac acquisitions (1525 seconds). After contrast-enhanced MR angiograms were acquired, they were downloaded to dedicated postprocessing workstations (UltraSparc 10; Sun Microsystems, Mountain View, Calif), where they were evaluated by using commercially available image-processing software (EasyVision, releases 3.0 and 4.0; Philips Medical Systems). The total examination time for contrast-enhanced MR angiography was approximately 2530 minutes.
Intraarterial DSA
We performed DSA by using an x-ray system (Diagnostic Arc; Philips Medical Systems) with a programmable stepping C-arm, a film changer (Puck; Elema-Schonander, Solina, Sweden), an add-on DSA system (Technicare DR 960-B; GE Medical Systems, Milwaukee, Wis), and a power injector (Medrad) until June 1998. After system upgrades, we used Integris V5000 (Philips Medical Systems) and Polystar (Siemens Medical Systems, Erlangen, Germany) digital angiography equipment. All intraarterial DSA examinations were supervised by one of three experienced board-certified interventional radiologists, who were unaware of the duplex US and MR angiography findings. These radiologists had 710 years of interventional radiologic experience.
Angiograms were obtained by using 4-F universal flush catheters (Cordis, Miami, Fla) that were placed in the infrarenal aorta. Iohexol (Omnipaque, 300 mg of iodine per milliliter; Amersham Health, Eindhoven, the Netherlands) was injected at flow rates ranging from 4 to 12 mL/sec, for a total of 50175 mL. In 13 patients, antegrade puncture angiography was performed by using a 5-F sheath (Cordis). The total amount of contrast medium used in these cases varied between 60 and 80 mL.
Time between Imaging Examinations
The mean delay between duplex US and MR angiography was 1 day ± 15 (standard deviation) (range, 60 days before to 63 days after MR angiography). The mean delay between duplex US and intraarterial DSA was 56 days ± 39 (range, 23127 days before intraarterial DSA), and the mean delay between MR angiography and intraarterial DSA was 51 days ± 43 (range, 22527 days before DSA).
Image Evaluation
The stenoses depicted at MR angiography and intraarterial DSA that were identified in arterial segments that were also imaged with duplex US were recorded. The following arteries were evaluated: the infrarenal aorta, the left and right common and external iliac arteries, and the common and superficial femoral arteries. Thus, a maximum of seven arterial segments per patient were evaluated. The iliac arteries were evaluated as a single arterial segment because 50% or greater stenosis in either vessel would lead to the same treatment. In each arterial segment, only the most severe stenosis was recorded. To determine the lengths and degrees of the stenoses from the MR angiography data, we used the routine clinical evaluation algorithm that was being used at our hospital at the time of the study. This algorithm involved evaluations of coronal, sagittal, and rotational maximum intensity projections. Rotational maximum intensity projections were generated at 30° increments from 0° to 150° and enabled us to view the vasculature from multiple angles.
The retrieval of MR angiography data and the generation of maximum intensity projections took about 5 minutes per patient. The severity of stenosis at MR angiography was classified by using the same five categories used for classification at duplex US and was calculated by dividing the luminal diameter at maximum stenosis by the luminal diameter of the closest adjacent normal part of the arterial segment.
At intraarterial DSA, anteroposterior views were obtained in all vascular regions. For the aortoiliac region, additional left and right anterior oblique projections at 25° were obtained. When intraarterial DSA data sets were available digitally, they were reviewed at the workstation; if no digital data sets were available, film hard-copy images were reviewed.
Four radiologists (G.B.C.V., M.W.d.H., K.Y.J.A.M.H., J.M.A.v.E.) with 68 years of experience interpreting contrast-enhanced MR angiograms determined the grades of the atherosclerotic lesions in the arterial segments, as defined previously. During the first reading, three radiologists evaluated 72 patient cases each, and the fourth radiologist evaluated 79 cases. Image interpretation took about 5 minutes per patient. To determine interobserver agreement, a second reading was performed after the first reading was completed. To avoid bias, the cases evaluated by each radiologist during the second reading were nearly evenly distributed among the three other radiologists. The results of the first reading were used to calculate sensitivity and specificity. Every MR angiogram reader was blinded to the findings of the other readers and to the duplex US and intraarterial DSA findings. Conversely, the duplex US image readers were blinded to the MR angiography and intraarterial DSA findings. The intraarterial DSA data sets were retrospectively read after inclusion for the study had ended, in consensus by two observers (T.L. and another observer, with, respectively, 6 and 10 years of experience in reading DSA images). The intraarterial DSA image readers were blinded to the results of the other imaging examinations. The duplex US images were interpreted by two vascular surgeons (P.E.J.H.M.K., J.H.M.T.) with, respectively, 20 and 15 years of duplex US experience.
Statistical Analyses
The McNemar test was used to test for significant differences in sensitivity and specificity between duplex US and MR angiography on an arterial segment level. Because we evaluated multiple arterial segments per patient, these observations were not independent. To correct for this dependency, we used an analysis in which clustered observations within each patient are accounted for. Accounting for this clustering is necessary for avoiding the underestimation of standard errors and for obtaining valid P values and confidence intervals (CIs) (Stata Users Guide, 8th ed; Stata, College Station, Tex).
Sensitivity, specificity, accuracy, and corresponding 95% CIs were calculated with the assumption that patients with negative results at both duplex US and MR angiography were considered to be true-negative cases. This assumption has no influence on the testing for differences in sensitivity and specificity between duplex US and MR angiography when the McNemar test is used. Agreement regarding MR angiogram readings was expressed in quadratic weighted
values (17). To investigate whether the delay between imaging examinations differed between the patients with concordant duplex US and MR angiography results and those with discordant results, the Mann-Whitney test was used. We used a nonparametric test because it was assumed that these delay times were not normally distributed. P < .05 was considered to indicate statistical significance. All statistical analyses were performed by using SPSS 11.0 (SPSS, Chicago, Ill) and STATA 8.0 (Stata, College Station, Tex).
| RESULTS |
|---|
|
|
|---|
Six hundred sixty-eight corresponding aortoiliac and superficial femoral arterial segments were available for the comparison between duplex US, MR angiography, and intraarterial DSA findings in 152 patients. The numbers and grades of lesions identified with duplex US, MR angiography, and intraarterial DSA are listed in Table 3.
|
|
|
|
|
|
value for agreement between the two MR angiography data readings regarding the five categories of stenosis was 0.89 (95% CI: 0.87, 0.91). | DISCUSSION |
|---|
|
|
|---|
However, both duplex US and MR angiography have limitations, and at present it is unclear which modality is more accurate in the diagnostic work-up of patients suspected of having PAD. The fact that there was little available information about the accuracy of duplex US versus that of contrast-enhanced MR angiography for the detection of suspected aortoiliac and superficial femoral PADespecially in the same patientsmotivated us to perform the current study.
In this study, the use of contrast-enhanced MR angiography instead of duplex US enabled better discrimination between patients with and those without significant stenosis in the aortoiliac or femoropopliteal arteries. It was shown that MR angiography is more sensitive than duplex US for the detection of angiographically significant stenosis in the diagnostic work-up of patients who present with intermittent claudication. The higher sensitivity of MR angiography is combined with its higher specificity; this means that the improved detection of stenoses with MR angiography is not achieved at the cost of more false-positive diagnoses of stenotic lesions.
In addition, the agreement between experienced contrast-enhanced MR angiography data readers regarding the classification of atherosclerotic lesions in the aortoiliac and superficial femoral arteries was observed to be high. The agreement between the two MR angiography data readings (quadratic
, 0.89) compares favorably with the
value reported in a relatively recent study of duplex US of the aortoiliac arteries (0.53) (19). The high interobserver agreement indicates that dedicated readers are interchangeable, and this interchangeability makes the technique acceptable in clinical practice.
The results of the present study corroborate the findings of the meta-analysis performed by Visser and Hunink (20), in which contrast-enhanced MR angiography was found to have greater discriminatory power over duplex US in the work-up of patients with PAD. In that study, a total of 295 patients were enrolled in 10 MR angiography studies in which examination results were analyzed. For duplex US, 21 studies, in which the examination results for a total of 1291 patients were analyzed, were performed. The pooled sensitivities of contrast-enhanced MR angiography and duplex US were 97.5% and 87.6%, respectively. Specificities were 96.2% for MR angiography and 94.7% for duplex US.
Thus far, two studies (21,22) in which duplex US was compared with contrast-enhanced MR angiography in the same patients have been published. In both studies, results similar to those observed in the current study were reported: sensitivities and specificities of duplex US of 72% and 88%, respectively (21), and of 72% and 97%, respectively (22). Sensitivities and specificities of contrast-enhanced MR angiography were 81% and 86%, respectively (21), and 88% and 92%, respectively (22). In the study by Wikstrom et al (21), however, there was considerable selection bias because nonconsecutive patients with iliac artery stenosis found at duplex US also underwent contrast-enhanced MR angiography and intraarterial DSA. In the study by Lundin et al (22), 39 patients who were already referred for intraarterial DSA also underwent contrast-enhanced MR angiography and duplex US.
In contrast, in the current prospective study, patients were randomly selected from a population of subjects who were referred for noninvasive evaluation because of reports of PAD from their vascular surgeons, and in this respect, this study was more representative of actual clinical practice. Although we were not able to include consecutive patients, the study population represented a random sample of patients who were scheduled to undergo duplex US in a given week during the study inclusion period.
A limitation of this study was that not all of the patients who had 50% or greater atherosclerotic lesions at duplex US, contrast-enhanced MR angiography, or both examinations underwent intraarterial DSA. To adjust the sensitivity and specificity values to account for this bias, we used sampling weights (Appendix). Surprisingly, the results of neither duplex US nor MR angiography, in terms of the presence or absence of greater than 50% stenosis, seemed to have a significant influence in the decision of whether or not to refer patients for intraarterial DSA. In addition to correcting for verification bias, we assumed that patients who had both negative duplex US results and negative contrast-enhanced MR angiography results did not have stenotic lesions, so a small number of segments with 50% or greater stenosis probably were falsely neglected. The effects of this assumption on the results of the study were that sensitivity and specificity values were probably slightly overestimated. However, this assumption influenced only the absolute estimates of sensitivity and specificity and had no influence on the testing of differences in sensitivity and specificity.
In addition, at logistic regression analysis, we found that only postexercise ABI was significantly associated with referral for intraarterial DSA. However, this finding does not exclude the fact that other important variables that were not considered in the present study are associated with referral for intraarterial DSA. Furthermore, the sensitivity and specificity values that we report were not directly derived from observations regarding the patients who underwent intraarterial DSA; rather, they are adjusted estimates, as explained in the Appendix.
Another limitation was the choice of intraarterial DSA as the reference standard. A better reference standard for the evaluation of aortoiliac lesions would have been intraarterial pressure measurements. This is because it is known that the stenosis percentages measured on intraarterial DSA images do not always correlate with either the true three-dimensional morphologic features or the hemodynamic effects of a given stenosis (21). For evaluation of the contrast-enhanced MR angiography data sets, it would have been better if source images or cross-sectional stenosis measurements also had been available. It is known that reading source images derived from contrast-enhanced MR angiography data sets increases diagnostic accuracy (10,23,24). In the current study, this probably would have resulted in MR angiography having higher sensitivity and specificity.
A final limitation is that different US transducers (3.5, 5.0, and 7.0 MHz) were used in different body regions and in patients with different weights. Although this factor may have influenced the results, this protocol was in keeping with current best clinical practices (25).
What are the implications of this study for clinical practice? Patients with PAD are best served when they undergo as little testing as possible to establish a diagnosis and to plan the appropriate therapy. The key clinical question is whether either contrast-enhanced MR angiography or duplex US is useful for predicting which patients are candidates for a simple local procedure (ie, percutaneous transluminal angioplasty or local endarterectomy) to treat focal disease. If either examination yields accurate results, the referring clinician can confidently inform a patient that angiography can be performed with percutaneous transluminal angioplasty at the same time or, conversely, that the disease is too diffuse and long segmented or an occlusive lesion is present that requires a more extensive or complex procedure such as aortofemoral bypass.
Many patients and some surgeons might be interested in treatment if angioplasty were possible, but they might be less interested if a major reconstruction were required. This approach enables one to avoid performing angiography in patients who are not good candidates for or do not desire major reconstructive surgery. In the current study, contrast-enhanced MR angiography and duplex US were nearly equally reliable in aiding in this selection for treatment of the superficial femoral artery, but MR angiography was more reliable in aiding in this selection for treatment of the aortoiliac arteries.
The contrast-enhanced MR angiography strategy that we used is robust for morphologic evaluation of peripheral arteries. It enables three-dimensional viewing of the peripheral arteries from the infrarenal aorta down to the ankles while allowing the patient to avoid undergoing intraarterial DSA. The extensive anatomic coverage and relatively short examination time are major advantages of the described contrast-enhanced MR angiography technique (16,26). Although duplex US also yields reliable information about peripheral arteries, it has lower accuracy, takes considerably longer to perform, and is subject to greater interobserver variation (19). On the other hand, the use of recently developed US contrast media may increase the diagnostic accuracy of duplex US, although experience with these agents is currently limited (27).
Another more recently developed three-dimensional imaging modality that shows promise for imaging peripheral arteries is multidetector row computed tomographic (CT) angiography (28). However, with CT angiography, as with intraarterial DSA, concerns about contrast medium nephrotoxicity and radiation exposure remain, as was shown in a study by Cochran et al (29). However, adverse reactions to intravenously injected gadolinium compounds also occur, but these reactions are generally less severe and occur at a much lower frequency than do those to CT contrast media, as was shown by Cochran et al (29).
In view of the results of the current study, we believe that the use of contrast-enhanced MR angiography as a primary imaging work-up examination for PAD in hospitals that have the necessary expertise and equipment is justified. We are currently investigating, in a multicenter trial, whether the use of contrast-enhanced MR angiography is cost-effective, given that it is more expensive than duplex US. In the event that contrast-enhanced MR angiography reveals equivocal findings, targeted duplex US of lesions of questionable severity can then be performed before proceeding to intraarterial DSA. In this context, it should be mentioned that not every patient is a suitable candidate for contrast-enhanced MR angiography because of contraindications such as claustrophobia and/or the presence of a pacemaker or certain other ferromagnetic implants (eg, some intracerebral vascular clips or otologic prostheses).
A technical limitation of contrast-enhanced MR angiography is that it does not yield information about stenoses and obstructions in most types of stents because of artifacts (30). A further drawback of contrast-enhanced MR angiography is that it is currently not as standardized as duplex US: Protocols are hardware and software dependent, and it is not clear if patients with PAD of different degrees of severity can be examined with the same protocol.
In conclusion, the findings of this study indicate that contrast-enhanced MR angiography is highly accurate for the detection and grading of PAD, given that the necessary equipment and expertise are available. Contrast-enhanced MR angiography has significantly and clinically important higher sensitivity compared with duplex US and is slightly more effective for diagnosing disease because of its higher specificity. On the basis of these findings and the potential capability of contrast-enhanced MR angiography to yield inflow and outflow information, we believe that contrast-enhanced MR angiography will have an increasingly important role in the diagnostic work-up of suspected PAD.
| APPENDIX |
|---|
|
|
|---|
In the group of subjects with a postexercise ABI below the mean and positive duplex US and/or contrast-enhanced MR angiography results, 70% (78 of 111) of patients were referred for intraarterial DSA. In the group of patients with a postexercise ABI above the mean, this percentage was 53% (45 of 85 patients), and in the group in which the ABI measurement was not successfully obtained, this percentage was 55% (29 of 53 patients). By weighting these strata with the inverse of these percentages, the original sample of patients who should have undergone intraarterial DSA can be reconstructed. Consequently, the first stratum should be weighted by 1.43 (1/0.70); the second stratum, by 1.89 (1/0.53); and the third stratum, by 1.82 (1/0.55).
Table A1 is a cross table for findings in the cohort of 249 patients who should have undergone intraarterial DSA after the described weights were applied to the data in Table 4. The data cited in this table were used to calculate sensitivity and specificity; however, this table cannot be used to determine variances because the cell numbers are artificially increased. Therefore, 95% CIs (not shown in Table) were calculated and McNemar testing for significant differences in sensitivity and specificity was performed with robust variances, according to the methods of Huber (31) and White (32,33).
|
| FOOTNOTES |
|---|
Authors stated no financial relationship to disclose.
Author contributions: Guarantors of integrity of entire study, T.L., A.G.H.K., P.J.N., J.M.A.v.E.; study concepts, T.L., K.Y.J.A.M.H., J.M.A.v.E.; study design, T.L., A.G.H.K., P.J.N., P.E. J.H.M.K., K.Y.J.A.M.H., J.M.A.v.E.; literature research, T.L.; clinical studies, T.L.; data acquisition, T.L., G.B.C.V., M.W.d.H., P.E.J.H.M.K., J.H.M.T.; data analysis/interpretation, T.L., A.G.H.K., P.J.N., J.M.A.v.E.; statistical analysis, T.L., A.G.H.K., P.J.N.; manuscript preparation and editing, T.L.; manuscript definition of intellectual content, revision/review, and final version approval, all authors
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Schillinger, S. Sabeti, P. Dick, J. Amighi, W. Mlekusch, O. Schlager, C. Loewe, M. Cejna, J. Lammer, and E. Minar Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting Circulation, May 29, 2007; 115(21): 2745 - 2749. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Thompson and R. House Hand-arm vibration syndrome with concomitant arterial thrombosis in the hands Occup. Med., August 1, 2006; 56(5): 317 - 321. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||